Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients

Rachel E. Tilley, Todd Holscher, Rajesh Belani, +2

Thrombosis Research

ThrombopoiesisThrombosisBlood PlateletMedicineHematology +11

Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality

Quansheng Zhou, Mili Kapoor, Min Guo, +10

Nature Structural & Molecular Biology

Orthogonal UseEngineeringTranslatomicsMolecular BiologySynthetic Biology +5

Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic health record data

Megan Braunlin, Rajesh Belani, Jacqueline Buchanan, +2

Leukemia & lymphoma/Leukemia and lymphoma

Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia

Taisuke Kanaji, My‐Nuong Vo, Sachiko Kanaji, +10

Proceedings of the National Academy of Sciences

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, +272

The Lancet Haematology

Hematological MalignancyOncologyTransplantationHematologyClinical Trials +6

Evidence for Annexin II-S100A10 Complex and Plasmin in Mobilization of Cytokine Activity of Human TrpRS

Mili Kapoor, Quansheng Zhou, Francella J. Otero, +8

Journal of Biological Chemistry

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho, +377

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Efficacy +4

Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy

Prasad L. Gawade, Shuling Li, David H. Henry, +4

Supportive Care in Cancer

Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

Caitlin Costello, Ben A Derman, Mehmet H. Kocoglu, +18

Blood

Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

Bhagirathbhai Dholaria, Mehmet H. Kocoglu, Andrew Kin, +18

Blood